Epidermal growth factor: receptor and ligand expression in human breast cancer
- PMID: 2103505
Epidermal growth factor: receptor and ligand expression in human breast cancer
Abstract
The epidermal growth factor (EGF) gene is expressed by most human breast cancer cell lines as well as 83% of human breast cancers in vivo. Furthermore, EGF mRNA is detectable in normal human breast tissue. These data suggest that EGF may have a functional role in both normal and neoplastic human breast tissue. Expression of EGF was generally highest in steroid receptor positive human breast tumor biopsies and cell lines. EGF expression was increased by progestins in T-47D and ZR 75 human breast cancer cells. Furthermore, progestins specifically increased the level of TGF-alpha and EGF-receptor mRNA in T-47D cells. Under these same conditions progestins inhibit growth of the cells. Regulation of expression of EGF, TGF-alpha and the EGF-receptor is unlikely to be directly related to the mechanism of progestin induced growth inhibition in T47-D cells. T-47D-5 cells are more sensitive than T-47D cells to progestin and antiestrogen induced growth inhibition. T-47D-5 cells do not express EGF and contain very low levels of TGF-alpha mRNA. The higher level of EGF and TGF-alpha expression in T-47D cells may be one mechanism by which these cells decrease their sensitivity to growth inhibition by progestins and antiestrogens.
Similar articles
-
Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.Cancer Res. 1991 Apr 15;51(8):2051-7. Cancer Res. 1991. PMID: 1849041
-
Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.Cancer Res. 1988 Aug 15;48(16):4555-60. Cancer Res. 1988. PMID: 3260816
-
Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.Cancer Res. 1989 Feb 1;49(3):599-604. Cancer Res. 1989. PMID: 2783382
-
Growth factor receptors and the progression of breast cancer.Semin Cancer Biol. 1990 Oct;1(5):317-28. Semin Cancer Biol. 1990. PMID: 1966491 Review.
-
Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins.Hum Reprod. 1994 Jun;9 Suppl 1:174-80. doi: 10.1093/humrep/9.suppl_1.174. Hum Reprod. 1994. PMID: 7962462 Review.
Cited by
-
Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase.J Cell Biol. 1995 Apr;129(1):47-54. doi: 10.1083/jcb.129.1.47. J Cell Biol. 1995. PMID: 7698994 Free PMC article.
-
Kinase inhibitors in cancer therapy: a look ahead.Drugs. 2000 Mar;59(3):435-76. doi: 10.2165/00003495-200059030-00004. Drugs. 2000. PMID: 10776829 Review.
-
Antiestrogen action and growth factor regulation.Breast Cancer Res Treat. 1994;31(1):61-71. doi: 10.1007/BF00689677. Breast Cancer Res Treat. 1994. PMID: 7981458 Review.
-
EGF-related peptides in the pathophysiology of the mammary gland.J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):143-51. doi: 10.1023/a:1026351730785. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882300 Review.
-
Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells.Breast Cancer Res. 2004;6(3):R239-45. doi: 10.1186/bcr780. Epub 2004 Mar 18. Breast Cancer Res. 2004. PMID: 15084247 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials